In the BioHarmony Drug Report Database
Micafungin, Mycamine (micafungin) is a small molecule pharmaceutical. Micafungin was first approved as Micafungin on 2005-03-16. It is used to treat candidemia and mycoses in the USA. It has been approved in Europe to treat candidiasis. Mycamine’s patent is valid until 2021-01-08 (FDA).
Image (chem structure or protein)